Veridex, LLC, a Johnson & Johnson company in vitro diagnostics oncology

Home

CellSearch

GeneSearch

News & Events

For Healthcare Professionals

The GeneSearch™ Breast Lymph Node Assay represents a breakthrough in intra-operative testing to help reduce second surgeries and hospital stays. This advanced molecular technology analyzes up to 50% of the node and offers objective and reproducible results. The test is commercially available in the US and EU.

If you are a patient, click here

Benefits of GeneSearch™

The GeneSearch™ Breast Lymph Node (BLN) Assay is the first-FDA approved molecular diagnostic assay for breast lymph node testing offering the chance for:

Fewer second surgeries and hospital stays
Rapid, reproducible, objective results
Detection of metastases greater than 0.2mm
Analyze up to 50% of the lymph node
Detects difficult to read lobular metastases with 80% sensitivity and 91% specificity

GeneSearch™ Video

Click to Play GeneSearch™ Video

GeneSearch™ Resources

Click Here To Access Instructions for Use

Product Overview

Click Here To Learn more about the BLN Assay